Thumbs up to you. Back it up another sentence. This sounds like they are considering spinning it out as one possibility. RGIN as a standalone, one product company was valued in the hundreds of millions even before the grant, ODD, RPDD potential, etc.
"We believe this program will dramatically change the practice of medicine in severe burn care, and is grossly undervalued inside Amarantus."
(13)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links